Kuiper, J., van Herk-Sukel, M., Castellsague, J., Pottegard, A., Anveden Berglind, I., Dedman, D., . . . Perez-Guttham, S. (2016). PSS64 - Utilization of Topical Tacrolimus and Topical Pimecrolimus in Europe: Results From The Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (Joelle) Study. Value in Health, 19(7), A573. https://doi.org/10.1016/j.jval.2016.09.1310
Chicago Style (17th ed.) CitationKuiper, JG, et al. "PSS64 - Utilization of Topical Tacrolimus and Topical Pimecrolimus in Europe: Results From The Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (Joelle) Study." Value in Health 19, no. 7 (2016): A573. https://doi.org/10.1016/j.jval.2016.09.1310.
MLA (9th ed.) CitationKuiper, JG, et al. "PSS64 - Utilization of Topical Tacrolimus and Topical Pimecrolimus in Europe: Results From The Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (Joelle) Study." Value in Health, vol. 19, no. 7, 2016, p. A573, https://doi.org/10.1016/j.jval.2016.09.1310.